valor de las acciones
Competidores
| Simbolo bursátil | Precio | Pronóstico 1A | Pronóstico 2A | Cap. Mercado | Div Yld | Tasa de crecimiento |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
760.00 | -48.06% | -26.74% | 684,308.09 | 0.68% | 2.63% |
|
NYSE:JNJ
Johnson & Johnson
|
149.91 | 0% | 0% | 360,785.28 | 3.31% | 2.71% |
|
NYSE:MRK
Merck
|
130.06 | -9.24% | 4.07% | 329,416.79 | 2.37% | -19.03% |
|
NYSE:ABBV
AbbVie
|
160.75 | -20.35% | -9.82% | 283,863.25 | 3.86% | 7.03% |
|
SWX:NOVN
Novartis
|
92.32 | 9.38% | 22.91% | 188,370.32 | 3.57% | 4.67% |
|
SWX:ROG
Roche Holding
|
225.10 | 32.03% | 48.13% | 181,774.36 | 4.26% | 0.43% |
|
NYSE:ABT
Abbott Laboratories
|
104.74 | 1.79% | 14.45% | 182,209.24 | 2.1% | 9.04% |
|
NasdaqGS:AMGN
Amgen
|
310.15 | -11.6% | -2.74% | 166,375.22 | 2.9% | 5.31% |
|
NYSE:PFE
Pfizer
|
28.01 | 10.86% | 41.77% | 158,721.27 | 6% | -9.31% |
|
ENXTPA:SAN
Sanofi
|
94.33 | 12.8% | 30.73% | 117,784.75 | 3.99% | 8.19% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.94 | 58.46% | 68.59% | 91,097.88 | 5.34% | 13.54% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
65.96 | 24.13% | 33.64% | 82,176.48 | 4.67% | 0.15% |
|
XTRA:MRK
Merck KGaA
|
155.50 | 10.7% | 26.55% | 67,607.96 | 1.41% | 10.29% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4129.00 | 0% | 0% | 6,478,127.87 | 4.75% | 0% |
|
NasdaqGS:BIIB
Biogen
|
221.50 | -11.75% | 3.9% | 32,249.71 | 0% | -10.89% |
|
XTRA:BAYN
Bayer
|
28.96 | 65.34% | 81.47% | 28,446.09 | 0.38% | 1.47% |
|
NYSE:TEVA
Teva Pharmaceutical Industries
|
16.25 | -46.07% | -42.6% | 18,405.41 | 0% | -2.6% |
|
NasdaqGS:INCY
Incyte
|
53.06 | 104.81% | 153.29% | 12,012.93 | 0% | 27.62% |
|
ENXTPA:IPN
Ipsen
|
119.90 | -14.58% | -6.56% | 9,878.9 | 1% | 9.14% |
|
NasdaqGS:EXEL
Exelixis
|
21.37 | 39.15% | 69.39% | 6,338.53 | 0% | -8.84% |
